Asklepios BioPharmaceutical is based in Research Triangle Park, N.C.. It has raised $235M in total funding. Latest round: Growth.
Asklepios BioPharmaceutical funding overview
Asklepios BioPharmaceutical is based in Research Triangle Park, N.C.. Asklepios BioPharmaceutical has raised $235M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in April 2019. The round record for Asklepios BioPharmaceutical runs through 2019; nothing later has been disclosed. Investors on record include TPG Capital, Vida Ventures. 2 distinct backers are named across the disclosed rounds.
Asklepios BioPharmaceutical at a glance
Total raised
$235M
Latest round
Growth
Latest round date
April 2019
Headquarters
Research Triangle Park, N.C.
Notable investors
TPG Capital, Vida Ventures
Frequently asked about Asklepios BioPharmaceutical funding
How much has Asklepios BioPharmaceutical raised?
Asklepios BioPharmaceutical has raised $235M in total disclosed funding across the rounds on record.
Who has invested in Asklepios BioPharmaceutical?
TPG Capital, Vida Ventures are named among the investors backing Asklepios BioPharmaceutical.
What was the latest Asklepios BioPharmaceutical funding round?
The most recent disclosed round is a Growth, announced in April 2019.
Where is Asklepios BioPharmaceutical based?
Asklepios BioPharmaceutical is based in Research Triangle Park, N.C..
When did Asklepios BioPharmaceutical last raise?
The last disclosed Asklepios BioPharmaceutical round closed in April 2019 at Growth.
Round data for Asklepios BioPharmaceutical is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Research Triangle Park and backer lists below.
Companies related to Asklepios BioPharmaceutical (12)
